marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

GOGL Acquires New Vessel

January 18, 2018

 Norway based dry bulk shipping company Golden Ocean Group Limited (GOGL) has  taken delivery of the second vessel, Sea Monterrey (to be renamed Golden Monterrey). 

 
On October 16, 2017 GOGL announced that it has entered into agreements to acquire two modern Capesize vessels from affiliates of Hemen Holding Limited, a company indirectly controlled by trusts established by John Fredriksen for the benefit of his immediate family (Hemen), the Company's largest shareholder, at a purchase price of USD 43.0 million per vessel.   
 
The first vessel, Golden Behike, was delivered in November 2017.  Bermuda registered GOGL has issued 2,000,000 shares to Hemen as part of the purchase price for the second vessel.
 
Following this transaction, the Company's issued share capital is USD 7,209,884.85 divided into 144,197,697 issued shares, each with a nominal value of USD 0.05.
 
GOGL owns and controls a fleet of 78 vessels including newbuildings and vessels chartered in on long term time charter contracts. 
 

Logistics News

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

ARC Freedom Enters ARC's U.S.-Flagged Fleet

ARC Freedom Enters ARC's U.S.-Flagged Fleet

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

Subscribe for Maritime Logistics Professional E‑News

Officials alter Danube entry procedure to address Ukrainian shipping queue
Sources say that traders are pushing for lower prices for Venezuelan crude oil, as shipping costs have risen.
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry